For millions of Americans, living with Type 2 Diabetes is an ongoing challenge – and the medical community is hard at work to identify and improve treatments to manage the disease, including right here in Rockville, Maryland.
It is from valuable efforts of clinical trial participants that improved treatments for current and future generations might occur.
Our study compares a new insulin taken once a week to insulin glargine (an insulin taken once daily which is already available on the market) in people with Type 2 Diabetes.